Kristen A. Rahn

Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis

Kristen A. Rahn, Crystal C. Watkins, Jesse Alt et al. · Proceedings of the National Academy of Sciences · 2012 · 72 citations · Full text

Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells

Ian S. Zagon, Kristen A. Rahn, Patricia J. McLaughlin · Neuropeptides · 2007 · 57 citations

Medicine, Cell Adhesion, Cell Trafficking +9

Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis

Kristen A. Rahn, Patricia J. McLaughlin, Ian S. Zagon · Brain Research · 2011 · 51 citations

Inflammation, Neurobiology Of Disease, Autoimmune Disease +14

Endogenous Opioids Regulate Expression of Experimental Autoimmune Encephalomyelitis: A New Paradigm for the Treatment of Multiple Sclerosis

Ian S. Zagon, Kristen A. Rahn, Anthony P. Turel et al. · Experimental Biology and Medicine · 2009 · 46 citations

Immunology, Neuroinflammation, Inflammation +18

Cognitive impairment in multiple sclerosis: a forgotten disability remembered.

Kristen A. Rahn, Barbara S. Slusher, Adam Kaplin · PubMed · 2012 · 43 citations · Full text

Cognitive Rehabilitation, Neuropsychology, Alzheimer's Disease +14